tiprankstipranks

Karen Dawes Insider Profile

25 Followers
Karen Dawes, Director at Repligen, holds 87.37K shares in Repligen (Ticker: RGEN), holds 1.70K shares in Barinthus Biotherapeutics (Ticker: BRNS), holds 84.59K shares in Assertio Therapeutics (Ticker: ASRT). Most recently, Karen Dawes Bought ― shares of Repligen on Feb 28, 2024 for an estimated value of 194.62K.
tipranks
Karen Dawes

Karen Dawes
Repligen (RGEN)
Director

Ranked #82,958 out of 98,624 Corporate Insiders

Profitable Transactions

40%
4 out of 10 Profitable Transactions

Average Return

-17.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$14M
99.41%
0.56%
0.03%
A breakdown of Karen Dawes's holdings

Insider Roles

Repligen
(RGEN)
Director
Assertio Therapeutics
(ASRT)
Director
Barinthus Biotherapeutics
(BRNS)
Director
Roles that Karen Dawes holds in companies

Most Profitable Insider Trade

Stock:
Repligen
(RGEN)
Rating:Informative Buy
Date:Jul 15, 2021 - Jul 15, 2022
Return:+31.10%
The most profitable trade made by Karen Dawes

Karen Dawes's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Repligen
Feb 28, 2024
Director
Informative Buy
194.62K
$13.84M
Barinthus Biotherapeutics
May 06, 2021
Director
Informative Buy
28.90K
$3.74K
Assertio Therapeutics
May 11, 2020
Director
Uninformative Sell
12.51K
$77.91K
PDLI
PDL BioPharma
$5.56K
List of latest transactions for each holding click on a transaction to see Karen Dawes's performance on stock

Karen Dawes insider profile FAQ

What is the percentage of profitable transactions made by Karen Dawes?
The percentage of profitable transactions made by Karen Dawes is 40%.
    What is the average return per transaction made by Karen Dawes?
    The average return per transaction made by Karen Dawes is -17.50%.
      What stocks does Karen Dawes hold?
      Karen Dawes holds: RGEN, BRNS, ASRT, PDLI stocks.
        What was Karen Dawes’s latest transaction?
        Karen Dawes latest transaction was an Informative Buy of $194.62K.
          What was Karen Dawes's most profitable transaction?
          Karen Dawes’s most profitable transaction was an Informative Buy of RGEN stock on July 15, 2021. The return on the trade was 31.10%.
            What is Karen Dawes's role in Repligen?
            Karen Dawes's role in Repligen is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.